Hyperthyroidism study in children
Treatments studied
Part of Hormones & metabolism clinical trials.
This study looks at children newly diagnosed with hyperthyroidism. It aims to learn more about the condition and how it affects kids who haven't been treated yet.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 14 years old or younger
- You have just been diagnosed with hyperthyroidism and have not taken any medication for it yet
- You do not have autoimmune hepatitis, viral hepatitis, blood diseases, or a history of bone marrow or liver transplant
- Your medical records are complete
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding vitamin D therapy to the usual Graves' disease treatment (methimazole) can improve thyroid function and lower antibody levels in children. If your child is between 9 and 17 and recently diagnosed, they may be able to participate.
This study observes people with various thyroid conditions, including overactive or underactive thyroid, to learn more about how these disorders develop and progress over time. It may help improve future diagnosis and treatment.
This study tests a wearable device called Glandy HYPER that helps doctors adjust your antithyroid medication dose for Graves' disease. It may offer a more precise and convenient way to manage your treatment.
This study looks at how well medication works for people with Graves' disease in China. It may help doctors understand the best treatment options for both new cases and relapses.
This study looks at children with autoimmune hyperthyroidism (an overactive thyroid caused by the immune system attacking the thyroid gland). Researchers want to understand this condition better in children before puberty to help improve care.
This study tests a new way to adjust thyroid medication doses for children with either congenital hypothyroidism or Graves' disease. It aims to help find the right dose more easily and improve treatment outcomes.
Hear when a new Hyperthyroidism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.